Hisamitsu Pharmaceutical Co (TSE:4530) Net Margin % : 10.30% (As of Nov. 2023)

View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Hisamitsu Pharmaceutical Co's Net Income for the three months ended in Nov. 2023 was 円3,693 Mil. Hisamitsu Pharmaceutical Co's Revenue for the three months ended in Nov. 2023 was 円35,850 Mil. Therefore, Hisamitsu Pharmaceutical Co's net margin for the quarter that ended in Nov. 2023 was 10.30%.

The historical rank and industry rank for Hisamitsu Pharmaceutical Co's Net Margin % or its related term are showing as below:

TSE:4530' s Net Margin % Range Over the Past 10 Years
Min: 8.04 Med: 11.49 Max: 13.98
Current: 9.86

TSE:4530's Net Margin % is ranked better than
68.92% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 3.225 vs TSE:4530: 9.86

Hisamitsu Pharmaceutical Co Net Margin % Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Net Margin % Chart

Hisamitsu Pharmaceutical Co Annual Data

Trend

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Net Margin %

Get a 7-Day Free Trial

13.26

8.08

8.04

9.15

9.86

Hisamitsu Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Net Margin %	Get a 7-Day Free Trial															6.09	12.62	12.52	10.30	4.78

Competitive Comparison of Hisamitsu Pharmaceutical Co's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hisamitsu Pharmaceutical Co's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's Net Margin % falls into.

Hisamitsu Pharmaceutical Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Hisamitsu Pharmaceutical Co's Net Margin for the fiscal year that ended in Feb. 2024 is calculated as

Net Margin	=	Net Income (A: Feb. 2024 )	/	Revenue (A: Feb. 2024 )
	=	13969	/	141706
	=	9.86 %

Hisamitsu Pharmaceutical Co's Net Margin for the quarter that ended in Nov. 2023 is calculated as

Net Margin	=	Net Income (Q: Nov. 2023 )	/	Revenue (Q: Nov. 2023 )
	=	3693	/	35850
	=	10.30 %

Hisamitsu Pharmaceutical Co (TSE:4530) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Hisamitsu Pharmaceutical Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hisamitsu Pharmaceutical Co (TSE:4530) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

HPX:Germany

Address

408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017

Website

http://www.hisamitsu.co.jp

Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (TSE:4530) Headlines

No Headlines